PLRX EPS Estimates
Pliant Therapeutics, Inc.
$0.90
-$0.07(-7.46%)
42
Overall
60
Value
45
Tech
23
Quality
Market Cap
$55.72M
Volume
582.72K
52W Range
$0.88 - $1.95
Target Price
$2.50
PLRX EPS estimates: the consensus estimate for Pliant Therapeutics, Inc.'s current fiscal year is -$1.42 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
PLRX EPS Estimates
- EPS estimate, current quarter
- $-0.37
- EPS estimate, next quarter
- $-0.37
- EPS estimate, current year
- $-1.42
- EPS estimate, next year
- $-1.53
- EPS growth, 3-year
- +6.15%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.43 |
| 2024 | $-3.47 |
| 2023 | $-2.75 |
| 2022 | $-2.94 |
| 2021 | $-2.71 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PLRX | $0.90 | -7.5% | 582.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Pliant Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW